TECH OUTLOOK 6DECEMBER - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comIn the pharma world, drug production and distribution is controlled by stringent laws set by regulatory boards across the globe. Failure to adhere to the regulations leads to hefty fines and other penalties. As compliance becomes a moving target, pharma companies are turning to advanced technologies to enhance the overall productivity and quality throughout the drug development and delivery processes. With patient life at stake, companies are using artificial intelligence and blockchain to stay ahead of the challenges and nip the challenges in the bud. With the growing market challenges, companies in the industry must ensure that every aspect of their operations, from R&D to drug dispatch, is performed with due diligence. As spurious drugs are lethal to patients, pharma firms must be equipped with the latest digital applications to track the entire journey of a drug, from the manufacturing unit to the consumer. An approach based on comprehensive monitoring and tracking will allow firms to effectively monitor the authenticity of the drugs, and for pharmacies and patients to check the origin of the product. While digital applications play a key role in enhancing the workflow across the board, the users must also understand how to utilize it to create safe production areas. Pharma companies must be knowledgeable of their operational systems architecture and the engineering and instrumentation management in establishing a proactive and quality-assured product delivery.In this edition of Pharma Tech Outlook, we highlight technology service providers that have a proven track record of enabling quality assurance in drug development and large-scale manufacturing. In addition, the edition also has key insights from the industry experts in the pharma sector on various topics. Let us know your thoughts.Genuine DrugsCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 16 - 2020, Vol 06 - Issue 30 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerRonald DonovanAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405TECH OUTLOOK
< Page 5 | Page 7 >